Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Adami, Eleonora Dr. (1) Akalin, Altuna Dr. (1) Blüthgen, Nils (1) Chen, Wei Prof. Dr. (2) Daniel, Peter Prof. Dr. (2) Gotthardt, Michael Prof. Dr. (1) Heinemann, Udo Prof. Dr. (2) Hinz, Michael Dr. (1) Hübner, Norbert Prof. Dr. (2) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (2) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (2) Landthaler, Markus Prof. Dr. (18) Leisegang, Matthias Prof. Dr. rer. nat. (3) Maatz, Henrike Dr. (1) Mastrobuoni, Guido Dr. (2) Ohler, Uwe Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (5) Rybak-Wolf, Agnieszka Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schütz, Anja Dr. (2) Selbach, Matthias Prof. Dr. (3) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (5) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (1) Wolf, Jana Prof. Dr. (1) Wurmus, Ricardo (1) Wyler, Emanuel Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (11) (-) Herzog, Margareta (1) Biologie maligner Lymphome (11) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (11) Proteom Dynamik (1) (-) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (4) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) (-) 2014 (4) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (5) 2024 (1) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Herzog, MargaretaMolekulare Immunologie und Gentherapie RNA Biologie und Posttranscriptionale Regulation201120142015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo 20. November 2014 / Cell A variety of dicer substrates in human and C. elegans A. Rybak-Wolf M. Jens Y. Murakawa M. Herzog M. Landthaler N. Rajewsky 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo 01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo
20. November 2014 / Cell A variety of dicer substrates in human and C. elegans A. Rybak-Wolf M. Jens Y. Murakawa M. Herzog M. Landthaler N. Rajewsky
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo
01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski